Antimicrobial stewardship: The need to cover all bases

Antibiotics

Volumn 2, Issue 3, 2013, Pages 400-418

  Friedman, N Deborah ^a,b  

^a BARWON HEALTH   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

Antibiotics; Antimicrobial; Resistance; Stewardship

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP; DECISION SUPPORT SYSTEM; EMERGENCY CARE; HEALTH CARE MANAGEMENT; HUMAN; INFORMATION TECHNOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; REVIEW; TELECONSULTATION; THERAPEUTIC MISCONCEPTION; UPPER RESPIRATORY TRACT INFECTION;

BACTERIA (MICROORGANISMS);

EID: 84977122316     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics2030400     Document Type: Review

References (116)

1. Cairns, K.; Jenney, A.; Doyle, J.; Skinner, M.; Doyle, J.; Dooley, M.; Cheng, A. C. Lessons from the Implementation of an Antimicrobial Stewardship Program. Presented at Annual Meeting of the Australian Society for Antimicrobials, Sydney, Australia, 21-23 February 2013.
2. Paterson, D. L. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin. Infect. Dis. 2006, 42, S90-S95.
3. Jones, R. N. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: A five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin. Respir. Crit. Care Med. 2003, 24, 121-134.
4. Levy, S. B.; O'Brien, T. F. Global antimicrobial resistance alerts and implications. Clin. Infect. Dis. 2005, 41, S219-S220.
5. Linden, P. K.; Kusne, S.; Coley, K.; Fontes, P.; Kramer, D. J.; Paterson, D. L. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin. Infect. Dis. 2003, 37, e154-e160.
6. D'Agata, E. M. C. Rapidly rising prevalence of nosocomial multidrug-resistant, gram-negative bacilli: A 9-year surveillance study. Infect. Control Hosp. Epidemiol. 2004, 25, 842-846.
7. Spellberg, B.; Guidos, R.; Gilbert, D.; Bradley, J.; Boucher, H. W.; Scheld, W. M.; Bartlett, J. G.; Edwards, J., Jr. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis. 2008, 46, 155-164.
8. Dellit, T. H.; Owens, R. C.; McGowan, J. E., Jr.; Gerding, D. N.; Weinstein, R. A.; Burke, J. P.; Huskins, W. C.; Paterson, D. L.; Fishman, N. O.; Carpenter, C. F.; et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship IDSA guideline on antimicrobial stewardship. Clin. Infect. Dis. 2007, 44, 159-177.
9. Parrino, T. A. Controlled trials to improve antibiotic utilization: A systematic review of experience, 1984-2004. Pharmacotherapy 2005, 25, 289-298.
10. MacKenzie, F. M.; Gould, I. M.; Bruce, J.; Mollison, J.; Monnet, D. L.; Krcmery, V.; Cookson, B.; van der Meer, J. W. M. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. J. Hosp. Infect. 2007, 65, 73-81.
11. Struelens, M. J. Multidisciplinary antimicrobial management teams: the way forward to control antimicrobial resistance in hospitals. Curr. Opin. Infect. Dis. 2003, 16, 305-307.
12. Bauer, K. A.; West, J. E.; Balada-Llasat, J.-M.; Pancholi, P.; Stevenson, K. B.; Goff, D. A. An antimicrobial stewardship program's impact. Clin. Infect. Dis. 2010, 51, 1074-1080.
13. Perez, K. K.; Olsen, R. J.; Musick, W. L.; Cernoch, P. L.; Davis, J. R.; Land, G. A.; Peterson, L. E.; Musser, J. M. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch. Pathol. Lab. Med. 2012, doi: 10. 5858/arpa. 2012-0651-OA.
14. Weller, T. M.; Jamieson, C. E. The expanding role of the antibiotic pharmacist. J. Antimicrob. Chemother. 2004, 54, 295-298.
15. Knox, K.; Lawson, W.; Dean, B.; Holmes, A. Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist-a UK perspective. J. Hosp. Infect. 2003, 53, 85-90.
16. Edwards, R.; Drumright, L. N.; Kiernan, M.; Holmes, A. Covering more territory to fight resistance: Considering nurses' role in antimicrobial stewardship. J. Infect. Prev. 2011, 12, 6-10.
17. Gross, R.; Morgan, A. S.; Kinky, D. E.; Weiner, M.; Gibson, G. A.; Fishman, N. O. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin. Infect. Dis. 2001, 33, 289-295.
18. De Souza, V.; Macfarlane, A.; Murphy, A. W.; Hanahoe, B.; Barber, A.; Cormican, M. A qualitative study of factors influencing antimicrobial prescribing by non-consultant hospital doctors. J. Antimicrob. Chemother. 2006, 58, 840-843.
19. Ibrahim, E. H.; Sherman, G.; Ward, S.; Fraser, V. J.; Kollef, M. H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118, 146-155.
20. Kollef, M. H.; Sherman, G.; Ward, S.; Fraser, V. J. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999, 115, 462-474.
21. Marcus, E. L.; Clarfield, A. M.; Moses, A. E. Ethical issues relating to the use of antimicrobial therapy in older adults. Clin. Infect. Dis. 2001, 33, 1697-1705.
22. Shlaes, D. M.; Gerding, D. N.; John, J. F., Jr.; Craig, W. A.; Bornstein, D. L.; Duncan, R. A.; Eckman, M. R.; Farrer, W. E.; Greene, W. H.; Lorian, V.; et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin. Infect. Dis. 1997, 25, 584-599.
23. Hsu, D. C.; Katalaris, C. H. Long-term management of patients taking immunosuppressive drugs. Aust. Prescr. 2009, 32, 68-71.
24. Septimus, E. J.; Owens, R. C. Need and potential of antimicrobial stewardship in community hospitals. Clin. Infect. Dis. 2011, 53, S8-S14.
25. Storey, D. F.; Pate, P. G.; Nguyen, A. T.; Chang, F. Implementation of an antimicrobial stewardship program on the medical-surgical service of a 100-bed community hospital. Antimicrob. Resist. Infect. Control 2012, 9, e32.
26. Laible, B. R.; Nazir, J.; Assimacopoulos, A. P.; Schut, J. Implementation of a pharmacist-led antimicrobial management team in a community teaching hospital: Use of pharmacy residents and pharmacy students in a prospective audit and feedback approach. J. Pharm. Pract. 2010, 23, 531-535.
27. Bennett, N. J.; Bull, A. L.; Dunt, D. R.; Russo, P. L.; Spelman, D. W.; Richards, M. J. Surgical antibiotic prophylaxis in smaller hospitals. ANZ J. Surg. 2006, 76, 676-678.
28. Russo, T. A.; Cook, S.; Gorbach, S. L. Intramuscular ceftriaxone in home parenteral therapy. Antimicrob. Agents Chemother. 1988, 32, 1439-1440.
29. Patel, I. H.; Chen, S.; Parsonnet, M.; Hackman, M. R.; Brooks, M. A.; Konikoff, J.; Kaplan, S. A. Pharmacokinetics of ceftriaxone in humans. Antimicrob. Agents. Chemother. 1981, 20, 634-641.
30. Wieland, B. W.; Marcantoni, J. R.; Bommarito, K. M.; Warren, D. K.; Marschall, J. A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus. Clin. Infect. Dis. 2012, 54, 585-590.
31. Paterson, D. L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Med. 2006, 119, S20-S28.
32. Hill, K. N. Responses to access block in Australia: The Alfred Hospital. Med. J. Aust. 2003, 178, 110-111.
33. Geelhoed, G. C.; de Klerk, N. H. Emergency department overcrowding, mortality and the 4-hour rule in Western Australia. Med. J. Aust. 2012, 196, 122-126.
34. Anomaly, J. Combating resistance: The case for a global antibiotics treaty. Public Health Ethics 2010, 3, 13-22.
35. Gould, I. M. Coping with antibiotic resistance: The impending crisis. Int. J. Antimicrob. Agents 2010, 36, S1-S2.
36. McDougall, D. A. J.; Morton, A. P.; Playford, E. G. Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia. J. Antimicrob. Chemother. 2013, 68, 457-460.
37. Roberts, R. R.; Hota, B.; Ahmad, I.; Scott, R. D.; Foster, S. D.; Abbasi, F.; Schabowski, S.; Kampe, L. M.; Ciavarella, G. G.; Supino, M.; et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: Implications for antibiotic stewardship. Clin. Infect. Dis. 2009, 49, 1175-1184.
38. Jones, A. I.; Dwyer, L. L.; Bercovitz, A. R.; Strahan, G. W. The National Nursing Home Survey: 2004 overview. Vital Health Stat. 2009, 167, 1-155.
39. Ribbe, M. W.; Ljunggren, G.; Steel, K.; Topinkova, E.; Hawes, C.; Ikegami, N.; Henrard, J.-C.; JÓ'Nnson, P. V. Nursing homes in 10 nations: A comparison between countries and settings. Age Ageing 1997, 26, 3-12.
40. US Census Bureau Public Information Office. An Older and More Diverse Nation by Midcentury. Available online: http://www. census. gov/newsroom/releases/archives/population (accessed on 27 May 2013).
41. Strausbaugh, L. J.; Joseph, C. L. The burden of infection in long-term care. Infect. Control Hosp. Epidemiol. 2000, 21, 674-679.
42. Juthani-Mehta, M.; Quagliarello, V. J. Infectious Diseases in the nursing home setting: Challenges and opportunities for clinical investigation. Clin. Infect. Dis. 2010, 51, 931-936.
43. Trick, W. E.; Weinstein, R. A.; DeMarais, P. L.; Kuehnert, M. J.; Tomaska, W.; Nathan, C.; Rice, T. W.; McAllister, S. K.; Carson, L. A.; Jarvis, W. R. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J. Am. Geriatr. Soc. 2001, 49, 270-276.
44. Gee, W. M. Causes of death in a hospitalized geriatric population: Autopsy study of 3000 patients. Virchows Arch. A. Pathol. Anat. Histopathol. 1993, 423, 343-349.
45. Brown, N. K.; Thompson, D. J. Nontreatment of fever in extended-care facilities. N. Engl. J. Med. 1979, 300, 1246-1250.
46. Smith, P. W.; Bennett, G.; Bradley, S.; Drinka, P.; Lautenbach, E.; Marx, J.; Mody, L.; Nicolle, L. E.; Stevenson, K. SHEA/APIC Guideline: Infection prevention and control in the long-term care facility. Infect. Control. Hosp. Epidemiol. 2008, 29, 785-814.
47. Gahr, P.; Harper, J.; Kieke, B.; Como-Sabetti, K.; Craig Christianson, R.; Williams, D.; Pederson, J.; Lynfield, R. Healthcare professional surveys: Judicious antibiotic use in Minnesota long-term care facilities. J. Am. Geriatr. Soc. 2007, 55, 473-474.
48. Nicolle, L. E.; Bentley, D. W.; Garibaldi, R.; Neuhaus, E. G.; Smith, P. W. Antimicrobial use in long-term care facilities. Infect. Control Hosp. Epidemiol. 2000, 21, 537-545.
49. Richards, C. L., Jr.; Darradji, M.; Weinberg, A.; Ouslander, J. G. Antimicrobial use in post-acute care: A retrospective descriptive analysis in seven long-term care facilities in Georgia. J. Am. Med. Dir. Assoc. 2005, 6, 109-112.
50. Crnich, C.; Dreis, M.; Hess, T.; Drinka, P.; Zimmerman, D. Patterns and Discrepancies between Different Metrics of Antibiotic Use in Nursing Homes. Presented at ID week, San Diego, CA, USA, 17-21 October 2012.
51. Benoit, S. R.; Nsa, W.; Richards, C. L.; Bratzler, D. W.; Shefer, A. M.; Steele, L. M.; Jernigan, J. A. Factors associated with antimicrobial use in nursing homes: A multilevel model. J. Am. Geriatr. Soc. 2008, 56, 2039-2044.
52. Lewis, S.; Agarwal, N.; Afolarin, H.; Isenberg, S.; Strong, S. Antibiotic stewardship in an inpatient rehabilitation hospital. Presented at ID week, San Diego, CA, USA, 17-21 October 2012.
53. Pate, P. G.; Storey, D. F.; Baum, D. L. Implementation of an antimicrobial stewardship program at a 60-bed long-term acute care hospital. Infect. Control Hosp. Epidemiol. 2012, 33, 405-408.
54. Schwartz, D. N.; Abiad, H.; DeMarais, P. L.; Armeanu, A.; Trick, W. E.; Wang, Y.; Weinstein, R. A. An educational intervention to improve antimicrobial use in a hospital-based long-term care facility. J. Am. Geriatr. Soc. 2007, 55, 1236-1242.
55. Jump, R. L. P.; Olds, D. M.; Seifi, N.; Kypriotakis, G.; Jury, L. A.; Peron, E. P.; Hirsch, A. A.; Drawz, P. E.; Watts, B.; Bonomo, R.; et al. Effective antimicrobial stewardship in a long-term care facility through an Infectious Diseases Consultation Service: Keeping a LID on antibiotic use. Infect. Control Hosp. Epidemiol. 2012, 33, 1185-1192.
56. Stuart, R. L.; Kotsanas, D.; Webb, B.; Vandergraaf, S.; Gillespie, E. E.; Hogg, G. G.; Korman, T. M. Prevalence of antimicrobial-resistant organisms in residential aged care facilities. Med. J. Aust. 2011, 195, 530-533.
57. Lim, C. J.; McLellan, S. C.; Cheng, A. C.; Culton, J. N.; Parikh, S. N.; Peleg, A. Y.; Kong, D. C. Surveillance of infection burden in residential aged care facilities. Med. J. Aust. 2012, 196, 327-331.
58. Moro, M. L.; Mongardi, M.; Marchi, M.; Taroni, F. Prevalence of long-term care acquired infections in nursing and residential homes in the Emilia-Romagna Region. Infection 2007, 35, 250-255.
59. Mylotte, J. M.; Keagle, J. Benchmarks for antibiotic use and cost in long-term care. J. Am. Geriatr. Soc. 2005, 53, 1117-1122.
60. McGeer, A.; Campbell, B.; Emori, T.; Hierholzer, W. J.; Jackson, M. M.; Nicolle, L. E.; Peppler, C.; Rivera, A.; Schollenberger, D. G.; Simor, A. E.; et al. Definitions of infection for surveillance in long-term care facilities. Am. J. Infect. Control 1991, 19, 1-7.
61. Goossens, H.; Ferech, M.; Coenen, S.; Stephens, P. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin. Infect. Dis. 2007, 44, 1091-1095.
62. Gould, I. M.; Mackenzie, F. M.; Struelens, M. J. Towards a European strategy for controlling antibiotic resistance. Clin. Microbiol. Infect. 2000, 6, 670-674.
63. Adriaenssens, N.; Coenen, S.; Versporten, A.; Muller, A.; Minalu, G.; Faes, C.; Vankerckhoven, V.; Aerts, M.; Hens, N.; Molenberghs, G.; et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient antibiotic use in Europe (1997-2009). J. Antimicrob. Chemother. 2001, 66, vi3-vi12.
64. Harbarth, S.; Albrich, W.; Brun-Buisson, C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: A sociocultural perspective. Emerg. Infect. Dis. 2002, 8, 1460-1467.
65. Akkerman, A. E.; Kuyvenhoven, M. M.; van der Wouden, J. C.; Verheij, T. J. Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J. Antimicrob. Chemother. 2005, 56, 930-936.
66. Cals, J. W.; Boumans, D.; Lardinois, R. J.; Gonzales, R.; Hopstaken, R. M.; Butler, C. C.; Dinant, G. J. Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study. Br. J. Gen. Pract. 2007, 57, 942-947.
67. McCaig, L. F.; Besser, R. E.; Hughes, J. M. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002, 19, 3096-3102.
68. Mangione-Smith, R.; McGlynn, E. A.; Elliott, M. N.; Krogstad, P.; Brook, R. H. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics 1999, 103, 711-718.
69. European Centre for Disease prevention and control. Available online: http://ecdc. europa. eu/en/eaad/activities/Pages/countryActivities. aspx (accessed on 27 May 2013).
70. European Centre for Disease prevention and control. Antibiotic Awareness Day. Toolkit for Engaging in Social Media Activities Promoting Prudent Antibiotic Use. Available online: http://ecdc. europa. eu/en/eaad/Documents/EAAD-social-media-guidance. pdf (accessed on 27 May 2013).
71. Centers for Disease Control and Prevention. Available online: http://www. cdc. gov/getsmart/(accessed on 27 May 2013).
72. Antibiotic Awareness Canada. Available online: http://antibioticawareness. ca/(accessed on 27 May 2013).
73. NPS MedicineWise. Available online: http://www. nps. org. au/conditions-and-topics/topics/campaigns-events/antibiotic-resistance-fighter (accessed on 27 May 2013).
74. Kristinsson, K. G. Modification of prescribers' behavior: The Icelandic approach. Clin. Microbiol. Infect. 1999, 5, S43-S47.
75. Goossens, H.; Coenen, S.; Costers, M.; de Corte, S.; de Sutter, A.; Gordts, B.; Laurier, L.; Struelens, M. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill. 2008, 13, pii: 19036.
76. Gottesman, B. S.; Carmelli, Y.; Shitrit, P.; Chowers, M. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin. Infect. Dis. 2009, 49, 869-875.
77. Sabuncu, E.; David, J.; Bernede-Bauduin, C.; Pepin, S.; Leroy, M.; Boelle, P.-Y.; Watier, L.; Guillemot, D. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009, 2, e1000084.
78. Mölstad, S.; Cars, O. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand. J. Infect. Dis. 1999, 31, 191-195.
79. Mölstad, S.; Erntell, M.; Hanberger, H.; Melander, E.; Norman, C.; Skoog, G.; Stålsby, C.; Lundborg, C.; Söderström, A.; Torell, E.; et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect. Dis. 2008, 8, 125-132.
80. Huttner, B.; Harbarth, S. "Antibiotics are not automatic anymore"-The French national campaign to cut antibiotic overuse. PLoS Med. 2009, 6, e1000080.
81. Ma, J.; Stafford, R. S.; Cockburn, I. M.; Finkelstein, S. N. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998. Clin. Ther. 2003, 25, 1503-1517.
82. Nathwani, D.; Sneddon, J.; Malcolm, W.; Wiuff, C.; Patton, A.; Hurding, S.; Eastaway, A.; Seaton, R.; Watson, E.; Gillies, E.; et al. Scottish Antimicrobial Prescribing Group (SAPG): Development and impact of the Scottish National Antimicrobial Stewardship Programme. Int. J. Antimicrob. Agents 2011, 38, 16-26.
83. Shakley, P.; Cairns, J.; Gould, I. M. Accelerated bacteriological evaluation in the management of lower respiratory tract infection in general practice. J. Antmicrob. Chemother. 1997, 39, 663-666.
84. Drusano, G. L. The crisis of resistance: Identifying drug exposures to suppress amplification of resistant mutant subpopulations. Clin. Infect. Dis. 2006, 42, 525-532.
85. Mouton, J. W.; Ambrose, P. G.; Canton, R.; Drusano, G. L.; Harbarth, S.; MacGowan, A.; Theuretzbacher, U.; Turnidge, J. Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist. Updates 2011, 14, 107-117.
86. Buising, K. L.; Thursky, K. A.; Robertson, M. B.; Black, J. K.; Street, A. C.; Richards, M. J.; Brown, G. V. Electronic antibiotic stewardship-Reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J. Antimicrob. Chemother. 2008, 62, 608-616.
87. Yong, M. K.; Buising, K. L.; Cheng, A. C.; Thursky, K. A. Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J. Antimicrob. Chemother. 2010, 65, 1062-1069.
88. Michaels, K.; Mahdavi, M.; Krug, A.; Kuper, K. Implementation of an antimicrobial stewardship program in a community hospital: Results of a three-year analysis. Hosp. Pharm. 2012, 47, 608-616.
89. Di Pentima, M.; Chan, S.; Eppes, S.; Klein, J. Antimicrobial prescription errors in hospitalized children: Role of antimicrobial stewardship program in detection and intervention. Clin. Pediatr. 2009, 48, 505-512.
90. Sintchenko, V.; Iredell, J. R.; Gilbert, G. L.; Coiera, E. Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care. J. Am. Med. Inform. Assoc. 2005, 12, 398-402.
91. Burdette, S. D.; Trotman, R.; Cmar, J. Mobile infectious disease references: From the bedside to the beach. Clin. Infect. Dis. 2012, 55, 114-125.
92. Mobile for Development Intelligence. Available online: https://mobiledevelopmentintelligence. com/impact_pathways/mhealth (accessed on 22 July 2013).
93. NPS MedicineWise. Available online: http://www. nps. org. au/conditions-and-topics/topics/how-to-be-medicinewise/managing-your-medicines/antibiotics-reminder (accessed on 22 July 2013).
94. Stanley, L.; Pestotnik, S. L. Expert clinical decision support systems to enhance antimicrobial stewardship programs insights society of infectious diseases pharmacists. Pharmacotherapy 2005, 25, 1116-1125.
95. Pestotnik, S. L.; Classen, D. C.; Evans, R. S.; Burke, J. P. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann. Intern. Med. 1996, 124, 884-890.
96. Samore, M. H.; Bateman, K.; Alder, S. C. Clinical decision support and appropriateness of antimicrobial prescribing: A randomized trial. JAMA 2005, 294, 2305-2314.
97. Filice, G. A.; Drekonja, D. M.; Thurn, J. R.; Rector, T. S.; Hammann, G. M.; Masoud, B. T.; Leuck, A.-M.; Nordgaard, C. L.; Eilertson, M. K.; Johnson, J. R. Use of a computer decision support system and antimicrobial therapy appropriateness. Infect. Control Hosp. Epidemiol. 2013, 34, 558-565.
98. Bright, T. J.; Wong, A.; Dhurjati, R.; Bristow, E.; Bastian, L.; Coeytaux, R. R.; Samsa, G.; Hasselblad, V.; Williams, J. W.; Musty, M. D. Effect of clinical decision support systems: A systematic review. Ann. Intern. Med. 2012, 157, 29-43.
99. Chaudhry, B.; Wang, J.; Wu, S.; Maglione, M.; Mojica, W.; Roth, E.; Morton, S. C.; Shekelle, P. G. Systematic review: Impact of health information technology on quality, efficiency, and costs of medical care. Ann. Intern. Med. 2006, 144, 742-752.
100. Classen, D. C.; Bates, D. W. Finding the meaning in meaningful use. N. Engl. J. Med. 2011, 365, 855-858.
101. Hermsen, E. D.; van Schooneveld, T. C.; Sayles, H.; Rupp, M. E. Implementation of a clinical decision support system for antimicrobial stewardship. Infect. Control Hosp. Epidemiol. 2012, 33, 412-415.
102. Ecker, D. J.; Sampath, R.; Li, H.; Massire, C.; Matthews, H. E.; Toleno, D.; Hall, T. A.; Blyn, L. B.; Eshoo, M. W.; Ranken, R.; et al. New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev. Mol. Diagn. 2008, 10, 399-415.
103. Caliendo, A. M. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin. Infect. Dis. 2011, 52, S326-S330.
104. Tissari, P.; Zumla, A.; Tarkka, E.; Mero, S.; Savolainen, L.; Vaara, M.; Aittakorpi, A.; Laakso, S.; Lindfors, M.; Piiparinen, H.; et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: An observational study. Lancet 2010, 375, 224-230.
105. Fenner, L.; Widmer, A. F.; Goy, G.; Rudin, S.; Frei, R. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J. Clin. Microbiol. 2008, 46, 328-330.
106. Gerber, M. A.; Shulman, S. T. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin. Microbiol. Rev. 2004, 17, 571-580.
107. Centers for Disease Control and Prevention. Detecting 2009 pandemic influenza A (H1N1) virus infection: Availability of diagnostic testing led to rapid pandemic response. Clin. Infect. Dis. 2011, 52, S36-S43.
108. Wassenberg, M. W.; Kluytmans, J. A.; Box, A. T.; Bosboom, R. W.; Buiting, A. G.; van Elzakker, E. P.; Melchers, W. J.; van Rijen, M. M.; Thijsen, S. F.; Troelstra, A.; et al. Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: A prospective study to evaluate costs and effects. Clin. Microbiol. Infect. 2010, 16, 1754-1761.
109. Simon, L.; Gauvin, F.; Amre, D. K.; Saint-Louis, P.; Lacroix, J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin. Infect. Dis. 2004, 39, 206-217.
110. Schuetz, P.; Briel, M.; Christ-Crain, M.; Stolz, D.; Bouadma, L.; Wolff, M.; Luyt, C. E.; Chastre, J.; Tubach, F.; Kristoffersen, K.; et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: An individual patient data meta-analysis. Clin. Infect. Dis. 2012, 55, 651-662.
111. Schuetz, P.; Albrich, W.; Christ-Crain, M.; Chastre, J.; Mueller, B. Procalcitonin for guidance of antibiotic therapy. Expert Rev. Anti Infect. Ther. 2010, 8, 575-587.
112. Muller, B.; Becker, K. L. Procalcitonin: How a hormone became a marker and mediator of sepsis. Swiss Med. Wkly. 2001, 131, 595-602.
113. Briel, M.; Schuetz, P.; Mueller, B.; Young, J.; Schild, U.; Nusbaumer, C.; Périat, P.; Bucher, H. C.; Christ-Crain, M. Procalcitonin-guided antibiotic use vs. a standard approach for acute respiratory tract infections in primary care. Arch. Intern. Med. 2008, 168, 2000-2007.
114. Kristoffersen, K. B.; Sogaard, O. S.; Wejse, C.; Black, F. T.; Greve, T.; Tarp, B.; Storgaard, M.; Sodemann, M. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission-A randomized trial. Clin. Microbiol. Infect. 2009, 15, 481-487.
115. Nobre, V.; Harbarth, S.; Graf, J. D.; Rohner, P.; Pugin, J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am. J. Respir. Crit. Care Med. 2008, 177, 498-505.
116. Bouadma, L.; Luyt, C. E.; Tubach, F.; Cracco, C.; Alvarez, A.; Schwebel, C.; Schortgen, F.; Lasocki, S.; Veber, B.; Dehoux, M.; et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010, 375, 463-474.